TY - JOUR JO - EuroIntervention TI - Angiographic maximal luminal diameter and appropriate deployment of the everolimus-eluting bioresorbable vascular scaffold as assessed by optical coherence tomography: an ABSORB cohort B trial sub-study AB - <p class="text-1er-paragraph"><span class="abstracts-titres" xml:lang="en-GB" style="font-size:1.11em;">Aims:</span> Bioresorbable vascular scaffolds (BVS) present different mechanical properties as compared to metallic platform stents. Therefore, AU - Gomez-Lara Josep AU - Diletti Roberto AU - Brugaletta Salvatore AU - Onuma Yoshinobu AU - Farooq Vasim AU - Thuesen Leif AU - McClean Dougal AU - Koolen Jacques J. AU - Ormiston A. John AU - Windecker Stephan AU - Whitbourn Robert J. AU - Dudek Dariusz AU - Dorange Cécile AU - Veldhof Susan AU - Rapoza J. Richard AU - Regar S. Evelyn AU - Garcia-Garcia M. Hector AU - Serruys Patrick W. VL - 8 IS - 2 Y1 - 27/06/2012 Y1 - 2012 DOI - SP - 214 EP - 224 KW - angiography KW - coronary artery disease KW - optical coherence tomography KW - optimal deployment KW - bioresorbable scaffold PB - Europa Digital & Publishing SE - Clinical research UR - https://eurointervention.pcronline.com/article/angiographic-maximal-luminal-diameter-and-appropriate-deployment-of-the-everolimus-eluting-bioresorbable-vascular-scaffold-as-assessed-by-optical-coherence-tomography-an-absorb-cohort-b-trial-sub-study SN - 1774-024X ER -